Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 811 entries
Sorted by: Best Match Show Resources per page
[The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency].

Zhurnal mikrobiologii, epidemiologii i immunobiologii

Mirchink EP, Pronin AV, Arion VIa, Deeva AV, Zimina IV, Zuev VA.
PMID: 2385991
Zh Mikrobiol Epidemiol Immunobiol. 1990 Apr;(4):60-4.

Viremia accompanying influenza infection and the possibility of transplacental passage of the virus into the fetus make it expedient to develop measures for the prophylaxis of intrauterine infection of the fetus in case of influenza during pregnancy. The work...

Cite
Mirchink EP, Pronin AV, Arion VIa, et al. Ispol'zovanie T-aktivina dlia profilaktiki vrozhdennoĭ grippoznoĭ infektsii u mysheĭ i korrektsii immunodefitsita. [The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency]. Zh Mikrobiol Epidemiol Immunobiol. 1990;(4):60-4
Mirchink, E. P., Pronin, A. V., Arion, V. I. a., Deeva, A. V., Zimina, I. V., & Zuev, V. A. (1990). Ispol'zovanie T-aktivina dlia profilaktiki vrozhdennoĭ grippoznoĭ infektsii u mysheĭ i korrektsii immunodefitsita. [The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, (4), 60-4.
Mirchink, E P, et al. "Ispol'zovanie T-aktivina dlia profilaktiki vrozhdennoĭ grippoznoĭ infektsii u mysheĭ i korrektsii immunodefitsita." [The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency]. Zhurnal mikrobiologii, epidemiologii i immunobiologii vol. ,4 (1990): 60-4.
Mirchink EP, Pronin AV, Arion VIa, Deeva AV, Zimina IV, Zuev VA. Ispol'zovanie T-aktivina dlia profilaktiki vrozhdennoĭ grippoznoĭ infektsii u mysheĭ i korrektsii immunodefitsita. [The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency]. Zh Mikrobiol Epidemiol Immunobiol. 1990 Apr;(4):60-4. Russian. PMID: 2385991.
Copy Download .nbib Format: NLM
ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.

Clinical pharmacy

[No authors listed]
PMID: 1312920
Clin Pharm. 1992 Feb;11(2):117-36.

No abstract available.

Cite
ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics. Clin Pharm. 1992;11(2):117-36
(1992). ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics. Clinical pharmacy, 11(2), 117-36.
"ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics." Clinical pharmacy vol. 11,2 (1992): 117-36.
ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics. Clin Pharm. 1992 Feb;11(2):117-36. PMID: 1312920.
Copy Download .nbib Format: NLM
[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].

Problemy tuberkuleza

Kossii NV, Khomenko IS, Gergert VIa.
PMID: 1780303
Probl Tuberk. 1991;(6):23-6.

Observation of 219 patients with pulmonary tuberculosis was made to study the effect of acute respiratory viral infection (ARVI) on the course of the disease. The affected were divided into 2 groups: 136 subjects who had ARVI and 83...

Cite
Kossii NV, Khomenko IS, Gergert VIa. Lechenie immunodefitsitnykh sostoianiĭ, vyzvannykh perenesennoĭ virusnoĭ infektsieĭ, otechestvennym immunomoduliatorom kemantanom u bol'nykh tuberkulezom legkikh. [Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis]. Probl Tuberk. 1991;(6):23-6
Kossii, N. V., Khomenko, I. S., & Gergert, V. I. a. (1991). Lechenie immunodefitsitnykh sostoianiĭ, vyzvannykh perenesennoĭ virusnoĭ infektsieĭ, otechestvennym immunomoduliatorom kemantanom u bol'nykh tuberkulezom legkikh. [Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis]. Problemy tuberkuleza, (6), 23-6.
Kossii, N V, et al. "Lechenie immunodefitsitnykh sostoianiĭ, vyzvannykh perenesennoĭ virusnoĭ infektsieĭ, otechestvennym immunomoduliatorom kemantanom u bol'nykh tuberkulezom legkikh." [Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis]. Problemy tuberkuleza vol. ,6 (1991): 23-6.
Kossii NV, Khomenko IS, Gergert VIa. Lechenie immunodefitsitnykh sostoianiĭ, vyzvannykh perenesennoĭ virusnoĭ infektsieĭ, otechestvennym immunomoduliatorom kemantanom u bol'nykh tuberkulezom legkikh. [Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis]. Probl Tuberk. 1991;(6):23-6. Russian. PMID: 1780303.
Copy Download .nbib Format: NLM
[Clinical use of colony-stimulating factors].

Vestnik Akademii meditsinskikh nauk SSSR

Tiuliandin SA, Garin AM.
PMID: 2192516
Vestn Akad Med Nauk SSSR. 1990;(2):54-8.

No abstract available.

Cite
Tiuliandin SA, Garin AM. Klinicheskoe primenenie koloniestimuliruiushchikh faktorov. [Clinical use of colony-stimulating factors]. Vestn Akad Med Nauk SSSR. 1990;(2):54-8
Tiuliandin, S. A., & Garin, A. M. (1990). Klinicheskoe primenenie koloniestimuliruiushchikh faktorov. [Clinical use of colony-stimulating factors]. Vestnik Akademii meditsinskikh nauk SSSR, (2), 54-8.
Tiuliandin, S A, and Garin, A M. "Klinicheskoe primenenie koloniestimuliruiushchikh faktorov." [Clinical use of colony-stimulating factors]. Vestnik Akademii meditsinskikh nauk SSSR vol. ,2 (1990): 54-8.
Tiuliandin SA, Garin AM. Klinicheskoe primenenie koloniestimuliruiushchikh faktorov. [Clinical use of colony-stimulating factors]. Vestn Akad Med Nauk SSSR. 1990;(2):54-8. Russian. PMID: 2192516.
Copy Download .nbib Format: NLM
[Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes].

Vrachebnoe delo

Antonenko VT, Polinkevich BS, Iusubov IuA, Kucher II.
PMID: 855280
Vrach Delo. 1977 Mar;(3):145-8.

No abstract available.

Cite
Antonenko VT, Polinkevich BS, Iusubov IuA, et al. Adoptivnaia i immunostimuliruishchaia terapiia bol'nykh s defitsitom immunologicheskoĭ aktivnosti limfotsitov [Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes]. Vrach Delo. 1977;(3):145-8
Antonenko, V. T., Polinkevich, B. S., Iusubov, I. u. A., & Kucher, I. I. (1977). Adoptivnaia i immunostimuliruishchaia terapiia bol'nykh s defitsitom immunologicheskoĭ aktivnosti limfotsitov [Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes]. Vrachebnoe delo, (3), 145-8.
Antonenko, V T, et al. "Adoptivnaia i immunostimuliruishchaia terapiia bol'nykh s defitsitom immunologicheskoĭ aktivnosti limfotsitov" [Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes]. Vrachebnoe delo vol. ,3 (1977): 145-8.
Antonenko VT, Polinkevich BS, Iusubov IuA, Kucher II. Adoptivnaia i immunostimuliruishchaia terapiia bol'nykh s defitsitom immunologicheskoĭ aktivnosti limfotsitov [Adoptive and immunostimulating therapy in patients with a deficit of immunoactive lymphocytes]. Vrach Delo. 1977 Mar;(3):145-8. Russian. PMID: 855280.
Copy Download .nbib Format: NLM
[Levamisole as an immunostimulant].

Orvosi hetilap

Pár A.
PMID: 882260
Orv Hetil. 1977 Jul 24;118(30):1759-62.

No abstract available.

Cite
Pár A. A levamisol mint immunstimulans. [Levamisole as an immunostimulant]. Orv Hetil. 1977;118(30):1759-62
Pár, A. (1977). A levamisol mint immunstimulans. [Levamisole as an immunostimulant]. Orvosi hetilap, 118(30), 1759-62.
Pár, A. "A levamisol mint immunstimulans." [Levamisole as an immunostimulant]. Orvosi hetilap vol. 118,30 (1977): 1759-62.
Pár A. A levamisol mint immunstimulans. [Levamisole as an immunostimulant]. Orv Hetil. 1977 Jul 24;118(30):1759-62. Hungarian. PMID: 882260.
Copy Download .nbib Format: NLM
Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy.

Clinical immunology and immunopathology

Hong R.
PMID: 3521966
Clin Immunol Immunopathol. 1986 Jul;40(1):136-41. doi: 10.1016/0090-1229(86)90077-2.

Correction of T-cell defects by either thymic hormone treatment or thymus transplantation has proven to be more difficult clinically than historically anticipated. Because the precise action of thymic hormones is unknown and because these hormones act upon post-thymic cells,...

Cite
Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol. 1986;40(1):136-41doi: 10.1016/0090-1229(86)90077-2.
Hong, R. (1986). Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clinical immunology and immunopathology, 40(1), 136-41. https://doi.org/10.1016/0090-1229(86)90077-2
Hong, R. "Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy." Clinical immunology and immunopathology vol. 40,1 (1986): 136-41. doi: https://doi.org/10.1016/0090-1229(86)90077-2
Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol. 1986 Jul;40(1):136-41. doi: 10.1016/0090-1229(86)90077-2. PMID: 3521966.
Copy Download .nbib Format: NLM
Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.

Experimental hematology

Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M.
PMID: 1354620
Exp Hematol. 1992 Sep;20(8):962-8.

High-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) in the treatment of malignancies is often associated with immune deficiency following transplantation, possibly contributing to tumor relapse or fatal infection. Interleukin 2 (IL-2), which enhances major histocompatibility complex (MHC)-unrestricted...

Cite
Bosly A, Guillaume T, Brice P, et al. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol. 1992;20(8):962-8
Bosly, A., Guillaume, T., Brice, P., Humblet, Y., Staquet, P., Doyen, C., Chatelain, B., Franks, C. R., Gisselbrecht, C., & Symann, M. (1992). Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Experimental hematology, 20(8), 962-8.
Bosly, A, et al. "Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors." Experimental hematology vol. 20,8 (1992): 962-8.
Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol. 1992 Sep;20(8):962-8. PMID: 1354620.
Copy Download .nbib Format: NLM
Results in two infants with the DiGeorge syndrome--effects of long-term TP5.

Clinical immunology and immunopathology

Businco L, Rubaltelli FF, Paganelli R, Galli E, Ensoli B, Betti P, Aiuti F.
PMID: 3084141
Clin Immunol Immunopathol. 1986 May;39(2):222-30. doi: 10.1016/0090-1229(86)90086-3.

We treated two patients affected by DiGeorge syndrome with long-term administration of the synthetic thymic hormone thymopoietin (TP5). In both cases we obtained durable immunological reconstitution, starting as early as 2 weeks after beginning of TP5 treatment. High levels...

Cite
Businco L, Rubaltelli FF, Paganelli R, et al. Results in two infants with the DiGeorge syndrome--effects of long-term TP5. Clin Immunol Immunopathol. 1986;39(2):222-30doi: 10.1016/0090-1229(86)90086-3.
Businco, L., Rubaltelli, F. F., Paganelli, R., Galli, E., Ensoli, B., Betti, P., & Aiuti, F. (1986). Results in two infants with the DiGeorge syndrome--effects of long-term TP5. Clinical immunology and immunopathology, 39(2), 222-30. https://doi.org/10.1016/0090-1229(86)90086-3
Businco, L, et al. "Results in two infants with the DiGeorge syndrome--effects of long-term TP5." Clinical immunology and immunopathology vol. 39,2 (1986): 222-30. doi: https://doi.org/10.1016/0090-1229(86)90086-3
Businco L, Rubaltelli FF, Paganelli R, Galli E, Ensoli B, Betti P, Aiuti F. Results in two infants with the DiGeorge syndrome--effects of long-term TP5. Clin Immunol Immunopathol. 1986 May;39(2):222-30. doi: 10.1016/0090-1229(86)90086-3. PMID: 3084141.
Copy Download .nbib Format: NLM
[Therapy of immunologic deficiencies in children].

Deutsche medizinische Wochenschrift (1946)

Oehme J, Ritter J.
PMID: 1091432
Dtsch Med Wochenschr. 1975 Mar 21;100(12):624-5. doi: 10.1055/s-0028-1106270.

No abstract available.

Cite
Oehme J, Ritter J. Behandlung von Immundefekten bei Kindern [Therapy of immunologic deficiencies in children]. Dtsch Med Wochenschr. 1975;100(12):624-5doi: 10.1055/s-0028-1106270.
Oehme, J., & Ritter, J. (1975). Behandlung von Immundefekten bei Kindern [Therapy of immunologic deficiencies in children]. Deutsche medizinische Wochenschrift (1946), 100(12), 624-5. https://doi.org/10.1055/s-0028-1106270
Oehme, J, and Ritter, J. "Behandlung von Immundefekten bei Kindern" [Therapy of immunologic deficiencies in children]. Deutsche medizinische Wochenschrift (1946) vol. 100,12 (1975): 624-5. doi: https://doi.org/10.1055/s-0028-1106270
Oehme J, Ritter J. Behandlung von Immundefekten bei Kindern [Therapy of immunologic deficiencies in children]. Dtsch Med Wochenschr. 1975 Mar 21;100(12):624-5. doi: 10.1055/s-0028-1106270. German. PMID: 1091432.
Copy Download .nbib Format: NLM
Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3.

Clinical immunology and immunopathology

Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A.
PMID: 2548783
Clin Immunol Immunopathol. 1989 Oct;53(1):24-31. doi: 10.1016/0090-1229(89)90097-4.

We investigated immunologic function in six cases with hypophosphatemic vitamin D-resistant rickets (VDRR) before and after treatment with 1 alpha-hydroxycholecalciferol (1 alpha(OH) vitamin D3). All cases suffered frequent episodes of infection, which tended to be more severe in the...

Cite
Kitajima I, Maruyama I, Matsubara H, et al. Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clin Immunol Immunopathol. 1989;53(1):24-31doi: 10.1016/0090-1229(89)90097-4.
Kitajima, I., Maruyama, I., Matsubara, H., Osame, M., & Igata, A. (1989). Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clinical immunology and immunopathology, 53(1), 24-31. https://doi.org/10.1016/0090-1229(89)90097-4
Kitajima, I, et al. "Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3." Clinical immunology and immunopathology vol. 53,1 (1989): 24-31. doi: https://doi.org/10.1016/0090-1229(89)90097-4
Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A. Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clin Immunol Immunopathol. 1989 Oct;53(1):24-31. doi: 10.1016/0090-1229(89)90097-4. PMID: 2548783.
Copy Download .nbib Format: NLM
[Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency].

Revista paulista de medicina

Naspitz CK, Sole D, Leser PG.
PMID: 2963364
Rev Paul Med. 1987 Jan-Feb;105(1):47-50.

No abstract available.

Cite
Naspitz CK, Sole D, Leser PG. Tratamento imunomodulador com cimetidina em pacientes com imunodeficiência comum variável. [Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency]. Rev Paul Med. 1987;105(1):47-50
Naspitz, C. K., Sole, D., & Leser, P. G. (1987). Tratamento imunomodulador com cimetidina em pacientes com imunodeficiência comum variável. [Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency]. Revista paulista de medicina, 105(1), 47-50.
Naspitz, C K, et al. "Tratamento imunomodulador com cimetidina em pacientes com imunodeficiência comum variável." [Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency]. Revista paulista de medicina vol. 105,1 (1987): 47-50.
Naspitz CK, Sole D, Leser PG. Tratamento imunomodulador com cimetidina em pacientes com imunodeficiência comum variável. [Immunomodulator therapy with cimetidine in patients with common variable immunodeficiency]. Rev Paul Med. 1987 Jan-Feb;105(1):47-50. Portuguese. PMID: 2963364.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 811 entries